These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 14613157

  • 41. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
    Nyunt MM, Plowe CV.
    Clin Pharmacol Ther; 2007 Nov; 82(5):601-5. PubMed ID: 17898709
    [Abstract] [Full Text] [Related]

  • 42. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL, Naval Medical Research Unit 2 Clinical Trial Team.
    Clin Infect Dis; 2002 Oct 01; 35(7):825-33. PubMed ID: 12228819
    [Abstract] [Full Text] [Related]

  • 43. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
    van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F.
    Clin Infect Dis; 2002 Dec 15; 35(12):1498-504. PubMed ID: 12471569
    [Abstract] [Full Text] [Related]

  • 44. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
    Vivas L, Rattray L, Stewart L, Bongard E, Robinson BL, Peters W, Croft SL.
    Acta Trop; 2008 Mar 15; 105(3):222-8. PubMed ID: 18279817
    [Abstract] [Full Text] [Related]

  • 45. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK, Van Vugt M, Paiphun L, Slight T, Looareesuwan S, White NJ, Nosten F.
    Am J Trop Med Hyg; 2005 Aug 15; 73(2):267-8. PubMed ID: 16103586
    [Abstract] [Full Text] [Related]

  • 46. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E, Bujanover S, Kain KC.
    Clin Infect Dis; 2003 Aug 01; 37(3):450-1. PubMed ID: 12884171
    [Abstract] [Full Text] [Related]

  • 47. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
    Kain KC, Shanks GD, Keystone JS.
    Clin Infect Dis; 2001 Jul 15; 33(2):226-34. PubMed ID: 11418883
    [Abstract] [Full Text] [Related]

  • 48. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA.
    J Travel Med; 2008 Jul 15; 15(5):302-6. PubMed ID: 19006502
    [Abstract] [Full Text] [Related]

  • 49. Clinical status and implications of antimalarial drug resistance.
    Winstanley PA, Ward SA, Snow RW.
    Microbes Infect; 2002 Feb 15; 4(2):157-64. PubMed ID: 11880047
    [Abstract] [Full Text] [Related]

  • 50. Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.
    Zimmerman PA.
    Am J Trop Med Hyg; 2003 Sep 15; 69(3):236-7. PubMed ID: 14628936
    [No Abstract] [Full Text] [Related]

  • 51. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
    Wilairatana P, Kyle DE, Looareesuwan S, Chinwongprom K, Amradee S, White NJ, Watkins WM.
    Ann Trop Med Parasitol; 1997 Mar 15; 91(2):125-32. PubMed ID: 9307653
    [Abstract] [Full Text] [Related]

  • 52. The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.
    Watkins WM, Sibley CH, Hastings IM.
    Am J Trop Med Hyg; 2005 Feb 15; 72(2):163-73. PubMed ID: 15741553
    [Abstract] [Full Text] [Related]

  • 53. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M, Grobusch MP, Gascon J, Matteelli A, Laferl H, Bisoffi Z, Ehrhardt S, Cuadros J, Hatz C, Gjorup I, McWhinney P, Beran J, da Cunha S, Schulze M, Kollaritsch H, Kern P, Fry G, Richter J, European Network on Surveillance of Imported Infectious Diseases.
    J Infect Dis; 2004 Nov 01; 190(9):1541-6. PubMed ID: 15478057
    [Abstract] [Full Text] [Related]

  • 54. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E, Demar M, Volney B, Ekala MT, Quinternet M, Bouchier C, Fandeur T, Rogier C, Carme B, Puijalon OM, Esterre P.
    Antimicrob Agents Chemother; 2007 Jun 01; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract] [Full Text] [Related]

  • 55. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J.
    Med Trop (Mars); 2002 Jun 01; 62(3):232-6. PubMed ID: 12244917
    [Abstract] [Full Text] [Related]

  • 56. Military aviators, special operations forces, and causal malaria prophylaxis.
    Chambers JA.
    Mil Med; 2003 Dec 01; 168(12):1001-6. PubMed ID: 14719625
    [Abstract] [Full Text] [Related]

  • 57. Malarone-donation programme in Africa.
    Bloland PB, Kazembe PN, Watkins WM, Doumbo OK, Nwanyanwu OC, Ruebush TK.
    Lancet; 1997 Nov 29; 350(9091):1624-5. PubMed ID: 9393355
    [Abstract] [Full Text] [Related]

  • 58. Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials.
    Fernandes JF, Lell B, Agnandji ST, Obiang RM, Bassat Q, Kremsner PG, Mordmüller B, Grobusch MP.
    Future Microbiol; 2015 Nov 29; 10(8):1375-90. PubMed ID: 26228767
    [Abstract] [Full Text] [Related]

  • 59. Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model.
    Wang H, Bei ZC, Wang JY, Cao WC.
    Exp Parasitol; 2011 Feb 29; 127(2):436-9. PubMed ID: 20868687
    [Abstract] [Full Text] [Related]

  • 60. [New antimalarial drugs].
    Ambroise-Thomas P.
    Rev Prat; 1998 Feb 01; 48(3):287-90. PubMed ID: 9781076
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.